Seretide Disc standard

Recall | Medicines | 22/02/2018

The marketing authorization holder has informed its supplied customers in a letter dated 22.02.2018 that it may not be possible to supply all doses. Therefore, the affected batch is recalled from the market as a precautionary measure.

Name of the medicinal product Seretide Diskus standard 50 Mikrogramm/250 Mikrogramm - einzeldosiertes Pulver zur Inhalation
Marketing authorisation number(s) 1-22901
Marketing authorisation holder GlaxoSmithKline Pharma GmbH
Batch number(s) 5K8W
Classification of the recall2
BASG reference number INS-640.001-2460

Further inquiry note